Cargando…
The Combined Use of in Silico, in Vitro, and in Vivo Analyses to Assess Anti-cancerous Potential of a Bioactive Compound from Cyanobacterium Nostoc sp. MGL001
Escalating incidences of cancer, especially in developed and developing countries, demand evaluation of potential unexplored natural drug resources. Here, anticancer potential of 9-Ethyliminomethyl-12-(morpholin-4-ylmethoxy)-5,8,13,16-tetraaza -hexacene-2,3-dicarboxylic acid (EMTAHDCA) isolated from...
Autores principales: | Niveshika, Verma, Ekta, Maurya, Shashank K., Mishra, Rajnikant, Mishra, Arun K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711831/ https://www.ncbi.nlm.nih.gov/pubmed/29230175 http://dx.doi.org/10.3389/fphar.2017.00873 |
Ejemplares similares
-
Structural Elucidation and Molecular Docking of a Novel Antibiotic Compound from Cyanobacterium Nostoc sp. MGL001
por: Niveshika,, et al.
Publicado: (2016) -
BMAA Inhibits Nitrogen Fixation in the Cyanobacterium Nostoc sp. PCC 7120
por: Berntzon, Lotta, et al.
Publicado: (2013) -
Ice-Binding Proteins Associated with an Antarctic Cyanobacterium, Nostoc sp. HG1
por: Raymond, James A., et al.
Publicado: (2021) -
Non-random genetic alterations in the cyanobacterium Nostoc sp. exposed to space conditions
por: Liu, Yuguang, et al.
Publicado: (2022) -
Draft Genome Sequence of the Symbiotically Competent Cyanobacterium Nostoc sp. Strain KVJ20
por: Halsør, Marie-Josée H., et al.
Publicado: (2019)